p53 Mutations in bladder tumors from arylamine-exposed workers

Cancer Research

Volumn 56, Issue 2, 1996, Pages 294-298

  Taylor, Jack A ^a   Li, Yu ^b   He, Mei ^b   Mason, Tom ^c   Mettlin, Curtis ^d   Vogler, William J ^e   Maygarden, Susan ^b   Liu, Edison ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINE;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; DNA FOOTPRINTING; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; NUCLEIC ACID BASE SUBSTITUTION; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; AMINES; BASE SEQUENCE; EXONS; GENES, P53; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTAGENS; OCCUPATIONAL DISEASES; POINT MUTATION; URINARY BLADDER NEOPLASMS;

EID: 0030046638     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA, 45: 8-30, 1995.
2. Kusser, W. C., Miao, X. L., Glickman, B. W., Friedland, J M , Rothman, N., Hemstreet, G. P., Mellot, J., Swan, D. C., Schulte, P. A., and Hayes, R. B p53 mutations in human bladder cancer. Environ. Mol Mutagen., 24: 156-160, 1994.
3. Shibata, A., Ohneseit, P. F., Tsai, Y. C., Spruck, C. H , Nichols, P. W , Chiang, H. S., Lai, M. K., and Jones, P. A. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis (Lond.), 15: 1085-1087, 1994.
4. Spruck, C. H., Ohneseit, P. F., Gonzalezzulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lemer, S P., Schmutte, C., Yang, A. S., Cote, R., Dubeau, L , Nichols, P. W., Hermann, G. G., Steven, K , Horn, T., Skinner, D. G , and Jones, P. A. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res , 54: 784-788, 1994.
5. Spruck, C H., III, Rideout, W. M., III, Olumi, A F., Ohneseit, P. F , Yang, A. S., Tsai, Y. C., Nichols, P. W., Horn, T., Hermann, G. G., Steven, K., Ross, R. K. Yu. M. C. and Jones, P. A. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Res., 55: 1162-1166, 1993.
6. Williamson, M. P. Elder, P. A., and Knowles, M. A. The spectrum of tp53 mutations in bladder carcinoma. Genes. Chromosomes & Cancer, 9: 108-118, 1994.
7. Habuchi, T., Takahashi, R., Yamada, H., Ogawa, O. Kakehi, Y., Ogura, K., Hamazaki, S., Toguchida, J., Ishizaki, K., Fujita, J., Sugiyama, T., and Yoshida, O. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res., 53: 3795-3799, 1993
8. Miyamoto, H., Kubota, Y., Shuin, T., Torigoe, S , Hosaka, M., Iwasaki, Y., Danenberg, K., and Danenberg, P. V Analyses of p53 gene mutations in primary human bladder cancer Oncol. Res., 5: 245-249, 1993.
9. Petersen, I., Ohgaki, H., Ludeke, B. I., and Kleihues, P. p53 mutations in phenacetin-associated human urothelial carcinomas. Carcinogenesis (Lond.), 14. 2119-2122, 1993.
10. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T., and Terada, M Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res , 52: 1393-1398, 1992
11. Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P , Summerhayes, I , Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., and Vogelstein, B Identification of p53 gene mutations in bladder cancers and urine samples. Science (Washington DC), 252: 706-709, 1991.
12. Suzuki, H., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., and Ueda, R p53 Mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52: 734-736, 1992.
13. Wieland, I. and Bohm, M Frequent allelic deletion at a novel locus on chromosome-5 in human lung cancer. Cancer Res., 54: 1772-1774, 1994
14. Taylor, J. A. Oncogenes and their applications in epidemiologic studies. Am. J Epidemiol , 130: 6-13, 1989.
15. Mason, T. J., Prorok, P. C., Neeld, W. E., and Vogler, W. J. Screening for bladder cancer at the Du Pont chambers works: initial findings. J. Occup Med., 28: 1011-1016, 1986.
16. Sarkar, F. H., Li, Y., and Crissman, J. D. A method for PCR sequencing of the p53 gene from a single 10 micron frozen or paraffin embedded tissue section. BioTechniques, 15. 36-37, 1993.
17. Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorbe, T., Hovig, E., Smithsorensen, B., Montesano, R., and Harris, C. C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22 3551-3555, 1994
18. Ziegler, A , Leffell, D. J., Kunala, S., Sharma, H. W., Gallant, M., Simon, J A., Halperin, A. J. Baden, H. P , Shapiro, P. E., Bale, A. E., and Brash, D. E. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers Proc. Natl. Acad. Sci. USA, 90: 4216-4220, 1993.
19. Chen, K. S., Peters, T. C., and Walker, J. R A minor arginine rRNA mutant limits translation preferentially of a protein dependent on the cognate codon. J Bacteriol., 772. 2504-2510, 1990.
20. Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., and Malcolm. S. Mutations in the fibroblast srowth factor receptor 2 gene cause Crouzon syndrome. Nat. Genet., 8: 98-103, 1994.
21. Puisieux, A , Lim, S. Groopman, J., and Ozturk, M. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51: 6185-6189, 1991.
22. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res., 54. 4855-4878, 1994.
23. Jones, P. A., Buckley, J. D., Henderson, B. E., Ross, R. K., and Pike, M. C. From gene to carcinogen: a rapidly evolving field in molecular epidemiology Cancer Res., 51: 3617-3620, 1991
24. Brash, D. E., Rudolph, J. A., Simon, J A., Lin, A., McKenna, G. J., Baden, H. P , Halperin, A. J., and Pontén, J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell careiaoma. Proc Natl Acad. Sci. USA, 88:
25. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature (Lond.), 350: 427-428, 1991.
26. Bressac, B , Kew, M , Wands, J , and Ozturk, M Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa Nature (Lond.), 350. 429-431, 1991
27. Taylor, J. A , Watson, M. A., Devereux, T. R., Michels, R Y., Saccomanno, G., and Anderson, M. p53 mutation hotspot in radon-associated lung cancer. Lancet, 343: 86-87, 1994.
28. Hoffmann, D , Masuda, Y , and Wynder, E I. α-naphthylamine and β-naphthylamine in cigarette smoke Nature (Lond.), 221: 254-256, 1969.
29. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z.-F., Sheinfeld, J., Fair, W. R., Heir, H W , and Reuter, V. E. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl. Cancer Inst., 85. 53-59, 1993.
30. Furihata, M., Inoue, K., Ohtsuki, Y. Hashimoto, H., Terao, N., and Fujita, Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcmoma of the urinary bladder Cancer Res., 53: 4823-4827, 1993.